Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1981 AL 1995

Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV

Milanini B, Valcour V.

Curr HIV/AIDS Rep. 2017 Aug;14(4):123-132. doi: 10.1007/s11904-017-0361-0.

Secretases-related miRNAs in Alzheimer's disease: new approach for biomarker discovery

Hajjari SN, Mehdizadeh M, Sadigh-Eteghad S, Shanehbandi D, Teimourian S, Baradaran B.

Neurol Sci. 2017 Nov;38(11):1921-1926. doi: 10.1007/s10072-017-3086-3. Epub 2017 Aug 8.

On the path to 2025: understanding the Alzheimer's disease continuum

Aisen PS, Cummings J, Jack CR Jr, Morris JC, Sperling R, Frölich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, Scheltens P, Dubois B.

Alzheimers Res Ther. 2017 Aug 9;9(1):60. doi: 10.1186/s13195-017-0283-5.

Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies

Lai KSP, Liu CS, Rau A, Lanctôt KL, Köhler CA, Pakosh M, Carvalho AF, Herrmann N.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):876-882. doi: 10.1136/jnnp-2017-316201. Epub 2017 Aug 9.

Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults

Li G, Mayer CL, Morelli D, Millard SP, Raskind WH, Petrie EC, Cherrier M, Fagan AM, Raskind MA, Peskind ER.

Neurology. 2017 Sep 19;89(12):1251-1255. doi: 10.1212/WNL.0000000000004392. Epub 2017 Aug 18.

Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components

Raghavan N, Tosto G.

Curr Neurol Neurosci Rep. 2017 Aug 21;17(10):78. doi: 10.1007/s11910-017-0787-1.

miRNAs in Alzheimer Disease - A Therapeutic Perspective

Gupta P, Bhattacharjee S, Sharma AR, Sharma G, Lee SS, Chakraborty C.

Curr Alzheimer Res. 2017;14(11):1198-1206. doi: 10.2174/1567205014666170829101016.

Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging

Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RD.

Neurology. 2017 Sep 26;89(13):1382-1390. doi: 10.1212/WNL.0000000000004425. Epub 2017 Aug 30.

Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports

Levy Nogueira M, Samri D, Epelbaum S, Lista S, Suppa P, Spies L, Hampel H, Dubois B, Teichmann M.

J Alzheimers Dis. 2017;60(2):577-583. doi: 10.3233/JAD-170574.

miRNAs Expressions and Interaction with Biological Systems in Patients with Alzheimer`s Disease. Using miRNAs as a Diagnosis and Prognosis Biomarker

Negoita SI, Sandesc D, Rogobete AF, Dutu M, Bedreag OH, Papurica M, Ercisli MF, Popovici SE, Dumache R, Sandesc M, Dinu A, Sas AM, Serban D, Corneci D.

Clin Lab. 2017 Sep 1;63(9):1315-1321. doi: 10.7754/Clin.Lab.2017.170327.

Exosomal biomarkers in Down syndrome and Alzheimer's disease

Hamlett ED, Ledreux A, Potter H, Chial HJ, Patterson D, Espinosa JM, Bettcher BM, Granholm AC.

Free Radic Biol Med. 2018 Jan;114:110-121. doi: 10.1016/j.freeradbiomed.2017.08.028. Epub 2017 Sep 5.

Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration

Festoff BW, Sajja RK, Cucullo L.

Biomed Res Int. 2017;2017:1549194. doi: 10.1155/2017/1549194. Epub 2017 Aug 14.

Sphingolipids in Alzheimer's Disease and Related Disorders

Martinez Martinez P, Mielke MM.

J Alzheimers Dis. 2017;60(3):753-756. doi: 10.3233/JAD-170735.

[Alzheimer's disease from Auguste Deter to the present : Progress, disappointments and open questions]

Pantel J.

Z Gerontol Geriatr. 2017 Oct;50(7):576-587. doi: 10.1007/s00391-017-1307-2. Epub 2017 Sep 18.

Relation of plasma selenium and lipid peroxidation end products in patients with Alzheimer's disease

Chmatalova Z, Vyhnalek M, Laczo J, Hort J, Pospisilova R, Pechova M, Skoumalova A.

Physiol Res. 2017 Dec 20;66(6):1049-1056. doi: 10.33549/physiolres.933601. Epub 2017 Sep 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias